# US 2025/0146056 A1 · Methods and systems for nucleic acid analysis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0146056 A1
- Document ID: US20250146056A1
- Status: Published application
- Kind: A1
- Application number: 18/945,336
- Filed: 2024-11-12
- Published: 2025-05-08
- Earliest claimed: 2020-10-15
- Assignees: 10x Genomics, Inc.
- Applicants: 10x Genomics, Inc.
- Inventors: Katherine PFEIFFER; Zahra Kamila BELHOCINE
- Web page: https://patentgrep.com/patent/US20250146056A1

## CPC

- C12Q 1/6813: Hybridisation assays
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q 2600/16: Primer sets for multiplex assays
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Provided herein are systems and methods for processing biomolecules (e.g., nucleic acid molecules, proteins) from a sample. A method for processing biomolecules may comprise barcoding the probe-nucleic acid molecule complex or derivatives thereof. Such a method can comprise performing a nucleic acid reaction, e.g., extension, denaturation, and amplification. The methods described herein may be performed within a partition, such as a droplet or well.

## Claims

### Claim 1

A method for processing a nucleic acid sample, comprising:
(a) providing a partition comprising:
(i) a first nucleic acid molecule comprising a first nucleic acid sequence and first capture sequence, wherein the first nucleic acid sequence is (I) a nucleic acid sequence or reverse complement thereof coupled to a labelling agent or (II) a CRISPR guide ribonucleic acid (gRNA) sequence or reverse complement thereof;
(ii) a first nucleic acid barcode molecule comprising a first barcode sequence and a second capture sequence; and
(iii) a splint nucleic acid molecule comprising a first splint sequence complementary the first capture sequence of the first nucleic acid molecule and a second splint sequence complementary to the second capture sequence of the first nucleic acid barcode molecule; and
(b) using the first nucleic acid molecule, the first nucleic acid barcode molecule, and the splint nucleic acid molecule to generate a first barcoded nucleic acid product comprising the first nucleic acid sequence or reverse complement thereof and the first barcode sequence or reverse complement thereof.

### Claim 2 (depends on 1)

The method of claim 1, further comprising ligating the first nucleic acid molecule to the first nucleic acid barcode molecule to generate the first barcoded nucleic acid product.

### Claim 3 (depends on 1)

The method of claim 1, wherein the first nucleic acid sequence comprises the nucleic acid sequence or reverse complement thereof coupled to the labelling agent.

### Claim 4 (depends on 1)

The method of claim 1, wherein the first nucleic acid sequence comprises the CRISPR gRNA sequence or reverse complement thereof.

### Claim 5 (depends on 1)

The method of claim 1, further comprising, prior to (a), generating the first nucleic acid molecule using a primer comprising the first capture sequence or complement thereof.

### Claim 6 (depends on 1)

The method of claim 1, wherein the first nucleic acid molecule comprises a complementary deoxyribonucleic acid (cDNA) comprising the reverse complement of the CRISPR gRNA sequence, and wherein generating the first nucleic acid molecule comprises reverse transcribing a CRISPR gRNA molecule comprising the CRISPR gRNA sequence.

### Claim 7 (depends on 1)

The method of claim 1, further comprising, in (a), providing a second nucleic acid molecule and a second nucleic acid barcode molecule comprising a second barcode sequence in the partition.

### Claim 8 (depends on 7)

The method of claim 7, further comprising using the second nucleic acid molecule and the second nucleic acid barcode molecule to generate a second barcoded nucleic acid product comprising a sequence of the second nucleic acid molecule, or reverse complement thereof, and the second barcode sequence, or reverse complement thereof.

### Claim 9 (depends on 8)

The method of claim 8, further comprising ligating the second nucleic acid molecule and the second nucleic acid barcode molecule to generate the second barcoded nucleic acid product.

### Claim 10 (depends on 7)

The method of claim 7, wherein the first barcode sequence and the second barcode sequence are the same sequence.

### Claim 11 (depends on 1)

The method of claim 1, further comprising, in (a), providing a third nucleic acid molecule comprising a tagmented deoxyribonucleic acid (DNA) fragment and a third nucleic acid barcode molecule comprising a third barcode sequence in the partition.

### Claim 12 (depends on 11)

The method of claim 11, further comprising using the third nucleic molecule and the third nucleic acid barcode molecule to generate a third barcoded nucleic acid product comprising a sequence of the tagmented DNA fragment or reverse complement thereof and the third barcode sequence or reverse complement thereof.

### Claim 13 (depends on 11)

The method of claim 11, further comprising, prior to (a), providing a biological particle comprising chromatin and generating the tagmented DNA fragment using a transposase coupled to an adaptor.

### Claim 14 (depends on 11)

The method of claim 11, wherein the first barcode sequence and the third barcode sequence are the same sequence.

### Claim 15 (depends on 1)

The method of claim 1, wherein the labelling agent comprises an antibody.

### Claim 16 (depends on 1)

The method of claim 1, wherein, in (a), the first nucleic acid barcode molecule is coupled to a support.

### Claim 17 (depends on 16)

The method of claim 16, further comprising, after (a), releasing the first nucleic acid barcode molecule from the support.

### Claim 18 (depends on 1)

The method of claim 1, further comprising subjecting the first barcoded nucleic acid product to an amplification reaction to generate a plurality of amplicons.

### Claim 19 (depends on 1)

The method of claim 1, further comprising sequencing the first barcoded nucleic acid product or a derivative thereof.
